Long-term use of rosuvastatin: a critical risk benefit appraisal and comparison with other antihyperlipidemics
Leonardo CalzaDepartment of Internal Medicine, Geriatrics and Nephrologic Diseases, Section of Infectious Diseases, “Alma Mater Studiorum” University of Bologna, S. Orsola-Malpighi Hospital, Bologna, ItalyAbstract: Rosuvastatin represents the latest inhibitor of 3-hydroxy...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-08-01
|
| Series: | Drug, Healthcare and Patient Safety |
| Online Access: | http://www.dovepress.com/long-term-use-of-rosuvastatin-a-critical-risk-benefit-appraisal-and-co-a3490 |